Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nutra Pharma, a biotechnology company that develops treatments for adrenomyeloneuropathy (AMN), HIV and multiple sclerosis (MS), has reported that its over-the-counter (OTC) pain reliever Cobroxin is available for purchase in CVS.
Subscribe to our email newsletter
Nutra Pharma claimed that Cobroxin is clinically proven to treat moderate to severe (Stage 2) chronic pain. Many other Stage 2 drugs require prescriptions, including Tylenol 3, Percocet, and Vicodin.
Cobroxin is currently available as an advanced oral spray for treating migraine headaches, neck aches, shoulder pain, cramps, lower back pain, and neuralgia and is also available as an advanced topical gel for treating joint pain and pain associated with repetitive stress and arthritis.
In 2009, Nutra Pharma had been granted an exclusive license to XenaCare Holdings to market and distribute Cobroxin in the US. Recently, XenaCare had announced that Cobroxin will be available for purchase in Walgreens by May 1, 2010.
Rik Deitsch, chairman and CEO of Nutra Pharma, said: “We are excited to announce the availability of Cobroxin in CVS, as this represents the first major drug store chain to carry Cobroxin nationwide. As an over-the-counter, non-narcotic, and non-addictive analgesic, we believe that Cobroxin will become the treatment of choice among those suffering from moderate to severe chronic pain.”